loading
前日終値:
$4.84
開ける:
$4.8
24時間の取引高:
5,653
Relative Volume:
0.03
時価総額:
$685.78M
収益:
$31.37M
当期純損益:
$-53.77M
株価収益率:
-3.2813
EPS:
-1.4537
ネットキャッシュフロー:
$-49.02M
1週間 パフォーマンス:
+9.15%
1か月 パフォーマンス:
+43.67%
6か月 パフォーマンス:
-31.95%
1年 パフォーマンス:
-78.32%
1日の値動き範囲:
Value
$4.76
$4.84
1週間の範囲:
Value
$4.36
$5.20
52週間の値動き範囲:
Value
$1.97
$22.71

Silence Therapeutics Plc Adr Stock (SLN) Company Profile

Name
名前
Silence Therapeutics Plc Adr
Name
セクター
Healthcare (1178)
Name
電話
44-0-20-3457 6900
Name
住所
72 HAMMERSMITH ROAD, LONDON
Name
職員
116
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
SLN's Discussions on Twitter

SLN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SLN
Silence Therapeutics Plc Adr
4.84 189.39M 31.37M -53.77M -49.02M -1.4537
Biotechnology icon
ONC
Beigene Ltd Adr
239.98 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.73 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.33 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.87 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.52 5.92B 0 -153.72M -103.81M -2.00

Silence Therapeutics Plc Adr Stock (SLN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-11 開始されました Goldman Sell
2024-12-02 繰り返されました BMO Capital Markets Outperform
2024-09-03 開始されました Jefferies Buy
2024-01-31 開始されました BMO Capital Markets Outperform

Silence Therapeutics Plc Adr (SLN) 最新ニュース

pulisher
May 22, 2025

Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade - MSN

May 22, 2025
pulisher
Mar 31, 2025

Silence Therapeutics stock hits 52-week low at $3.19 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Silence Therapeutics stock hits 52-week low at $3.19 - Investing.com

Mar 31, 2025
pulisher
Mar 21, 2025

Silence Therapeutics (SLN) Upgraded to Buy: Here's What You Should Know - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Silence Therapeutics stock hits 52-week low at $3.66 amid downturn - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Silence Therapeutics stock hits 52-week low at $3.66 amid downturn By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 18, 2025

Taiwan Semiconductor Valuation: How Realistic Is the Price? - The Globe and Mail

Mar 18, 2025
pulisher
Mar 13, 2025

Silence Therapeutics stock hits 52-week low at $4.04 amid challenges - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Silence Therapeutics stock hits 52-week low at $4.04 amid challenges By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Silence Therapeutics sees stock rise post-earnings - Investing.com

Feb 27, 2025
pulisher
Feb 20, 2025

BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment - GlobeNewswire Inc.

Feb 20, 2025
pulisher
Feb 11, 2025

Goldman Sachs cuts Silence Therapeutics stock rating to Sell By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 11, 2025

Should investors be concerned about Silence Therapeutics Plc ADR (SLN)? - US Post News

Feb 11, 2025
pulisher
Feb 11, 2025

Akoya Biosciences Inc (AKYA)’s Day in Review: Closing at 2.34, Down by -4.88 - The Dwinnex

Feb 11, 2025
pulisher
Feb 10, 2025

Cloudflare Inc’s (NET) Stock: A 29.10% Simple Moving Average for the Past 20 Days - The News Heater

Feb 10, 2025
pulisher
Feb 03, 2025

Silence Therapeutics's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Feb 03, 2025
pulisher
Feb 03, 2025

Silence Therapeutics's SWOT analysis: stock poised for growth amid challenges - Investing.com

Feb 03, 2025
pulisher
Feb 03, 2025

H.C. WAINWRIGHT MAINTAINS $75 TARGET ON SILENCE THERAPEUTICS STOCK By Investing.com - Investing.com South Africa

Feb 03, 2025
pulisher
Jan 07, 2025

European Equities Traded in US as American Depositary Receipts Surge on Monday - MSN

Jan 07, 2025
pulisher
Dec 18, 2024

Top 3 Health Care Stocks That May Explode In Q4 - Benzinga

Dec 18, 2024
pulisher
Dec 17, 2024

Silence Therapeutics' SWOT analysis: stock's potential in RNAi therapeutics - Investing.com

Dec 17, 2024
pulisher
Dec 10, 2024

Silence Therapeutics' SWOT analysis: RNAi stock poised for growth amid clinical progress - Investing.com India

Dec 10, 2024
pulisher
Dec 09, 2024

Silence Therapeutics announces additional results from SANRECO study - TipRanks

Dec 09, 2024
pulisher
Nov 24, 2024

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - MSN

Nov 24, 2024
pulisher
Nov 19, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Silence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

SILENCE THERAPEUTICS PLC SPONSORED ADR trading resumes - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga

Nov 19, 2024
pulisher
Nov 17, 2024

Silence Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 17, 2024
pulisher
Nov 14, 2024

Silence Therapeutics: Rising Assets Amid Growing Losses - TipRanks

Nov 14, 2024
pulisher
Sep 25, 2024

Biogen's Lupus Candidate Meets Key Goals in Phase III Study - Yahoo Finance

Sep 25, 2024
pulisher
Aug 07, 2024

The 3 Best Gene Editing Stocks to Buy in August 2024 - Markets Insider

Aug 07, 2024
pulisher
Jun 20, 2024

Zerlasiran shows promise in phase 2 study for cardiovascular risk - Investing.com India

Jun 20, 2024
pulisher
Feb 16, 2024

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 16, 2024
pulisher
Dec 15, 2023

Here's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep going - MSN

Dec 15, 2023
pulisher
Nov 01, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 01, 2023
pulisher
Jun 01, 2023

Claire Keast-Butler - Cooley

Jun 01, 2023
pulisher
Apr 21, 2023

Our approach to nucleotide-based therapeutics - AstraZeneca

Apr 21, 2023
pulisher
Feb 06, 2023

Silence Therapeutics Plc ADR (SLN-Q) QuotePress Release - The Globe and Mail

Feb 06, 2023
pulisher
Jan 18, 2023

5 Stocks to Buy as the Drug Industry Bets Big on Innovation - Nasdaq

Jan 18, 2023
pulisher
Jan 04, 2023

Silence Therapeutics PLC Sponsored ADR (SLN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Jan 04, 2023
pulisher
Dec 30, 2020

Genfit (NASDAQ:GNFT) Stock Quotes, Forecast and News Summary - Benzinga

Dec 30, 2020
pulisher
Dec 14, 2017

Silence Therapeutics (SLN) - Zacks Investment Research

Dec 14, 2017

Silence Therapeutics Plc Adr (SLN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.19
price down icon 13.67%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$285.24
price down icon 1.09%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
大文字化:     |  ボリューム (24 時間):